Clinical Trial Update: Investigating the Mu:Kappa Opioid Receptor Imbalance in Alcohol Use Disorder [EARLY_Phase 1]

View source ↗

Summary

This early-phase clinical trial from Yale University is investigating mu:kappa opioid receptor imbalance as a potential mechanism and treatment target for Alcoh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Snippet

Sponsor: Yale University | Conditions: Alcohol Use Disorder | EARLY_Phase 1 | Status: RECRUITING